SKLB 610
SKLB610 is a novel multi-targeted tyrosine kinase inhibitor. At 10 μM, it potently inhibits VEGFR2 (97%), FGFR2 (65%), and PDGFR (55%) in biochemical assays. This profile supports its research use in studying angiogenesis and tumor growth in both cellular and animal models.
Product Specifications
CAS Number
1125780-41-7
Product Name Alternative
PDGFR, FGFR, SKLB610, SKLB-610, SKLB 610, VEGFR
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.88% (May vary between batches)
Solubility
DMSO:50 mg/mL (120.37 mM)
Smiles
O (C=1C=C (C (NC) =O) N=CC1) C2=CC=C (NC (=O) C3=CC (C (F) (F) F) =CC=C3) C=C2
Molecular Formula
C21H16F3N3O3
Molecular Weight
415.37
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CRB1001598-01 0.5 mg
Spexin 2 (53-70) Human, Mouse, Rat - (Peptide)
Sign In for Pricing
View Details ARP31638_P050-HRP 100 µL
ELF2 Antibody - N-terminal region : HRP (ARP31638_P050-HRP)
Sign In for Pricing
View Details bsm-33412M-BF350 100 µL
Bcl-2 monoclonal Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details